• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

RNAIII (RIP) & Deriv. as potential tools for the treatment of S. aureus biofilm infections

Bioengineer by Bioengineer
December 16, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Antonio Di Stefano et al. is published in Current Topics in Medicinal Chemistry, Volume 18, 32 Issues, 2018

Stephano and his coworkers at the University “G. d’Annunzio” of Chieti, Italy, have reviewed the inhibiting potential of RNAIII Inhibiting Peptide (RIP) for the treatment of biofilm producing S. aureus infections.

Bacterial cells can grow in two ways, one as single cells or in the form of aggregates which normally form biofilms. Biofilms are mainly associated with the enhancement of virulence of the strains. This is because biofilms protect bacterial cells from antimicrobial agents as they are usually impermeable, while providing physical defense against the host’s own immune response and allowing bacterial cells to produce pathogenic toxins in larger quantities. Bacteria in biofilms are therefore able to survive by producing cells that can survive high antibiotic concentrations. Therefore, the use of traditional antimicrobial agents solely is not considered an effective treatment for the infections caused by biofilm producing strains.

Hospital-acquired and post-surgical infections, specifically due to the use of indwelling medical devices like catheters, prosthesis etc. are often associated with bacterial growth under the influence of biofilm formation by Staph. aureus.

By studying biofilms, researchers can devise treatment strategies to treat difficult and potentially life threatening bacterial infections. One such strategy is to prevent the formation of biofilms. Bacteria are able to form biofilms through a cell-cell communication process known as quorum sensing (QS).

Quorum sensing was discovered to be mediated by RNA-III activating peptide (RAP) and its target protein, TRAP. Disrupting this interaction results in a decreased adhesion of bacterial cells to each other which further leads to a disruption in the biofilm formation cycle. Unable to form a biofilm, bacteria are therefore unable to produce as much toxins while being more vulnerable to the host’s defenses.

RNA-III inhibiting peptides (RIPs) and their derivatives are considered as a potential tool for disrupting this quorum sensing mechanism in S. aureus.

Stephano et al. explain the process of biofilm formation and the proposed method of disrupting the process with RIPs and their derivatives. In addition, they present an overview of RIP structure, mechanism of action, in vitro/in vivo studies to treat infections, and RIP structure-activity studies. This treatise on the medicinal chemistry of RIPs gives the reader an insight into a new strategy that has the potential to treat chronic and complicated S. aureus infections.

###

This article is Open Access. To obtain the article please visit http://www.eurekaselect.com/166501

Media Contact
Faizan ul Haq
[email protected]
http://dx.doi.org/10.2174/1568026618666181022120711

Tags: BiochemistryBiomedical/Environmental/Chemical EngineeringMedicine/HealthPharmaceutical SciencesPharmaceutical/Combinatorial Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

Classifying Malignant Colon Polyps via OCT

September 26, 2025
Caspase-8–Meteorin Roles in MASH, Fibrosis

Caspase-8–Meteorin Roles in MASH, Fibrosis

September 26, 2025

Deep Learning Advances Left Atrial Imaging

September 26, 2025

Injury-Linked Lobular Niche Drives Pancreatic Tumors

September 26, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    78 shares
    Share 31 Tweet 20
  • Physicists Develop Visible Time Crystal for the First Time

    72 shares
    Share 29 Tweet 18
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    55 shares
    Share 22 Tweet 14
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Classifying Malignant Colon Polyps via OCT

Caspase-8–Meteorin Roles in MASH, Fibrosis

FTO Modulates MZF1 to Enhance Fatty Acid Oxidation

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.